JP2022501436A5 - - Google Patents
Info
- Publication number
- JP2022501436A5 JP2022501436A5 JP2021539501A JP2021539501A JP2022501436A5 JP 2022501436 A5 JP2022501436 A5 JP 2022501436A5 JP 2021539501 A JP2021539501 A JP 2021539501A JP 2021539501 A JP2021539501 A JP 2021539501A JP 2022501436 A5 JP2022501436 A5 JP 2022501436A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- heterocycle
- alkyl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024152701A JP2024163257A (ja) | 2018-09-18 | 2024-09-04 | 非アルコール性脂肪性肝疾患に対する処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732644P | 2018-09-18 | 2018-09-18 | |
| US62/732,644 | 2018-09-18 | ||
| PCT/US2019/051790 WO2020061232A1 (en) | 2018-09-18 | 2019-09-18 | Treatment for non-alcoholic fatty liver disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152701A Division JP2024163257A (ja) | 2018-09-18 | 2024-09-04 | 非アルコール性脂肪性肝疾患に対する処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501436A JP2022501436A (ja) | 2022-01-06 |
| JP2022501436A5 true JP2022501436A5 (enExample) | 2022-10-04 |
| JP7557788B2 JP7557788B2 (ja) | 2024-09-30 |
Family
ID=69888816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539501A Active JP7557788B2 (ja) | 2018-09-18 | 2019-09-18 | 非アルコール性脂肪性肝疾患に対する処置 |
| JP2024152701A Pending JP2024163257A (ja) | 2018-09-18 | 2024-09-04 | 非アルコール性脂肪性肝疾患に対する処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152701A Pending JP2024163257A (ja) | 2018-09-18 | 2024-09-04 | 非アルコール性脂肪性肝疾患に対する処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12318381B2 (enExample) |
| EP (1) | EP3852753A4 (enExample) |
| JP (2) | JP7557788B2 (enExample) |
| KR (1) | KR102890555B1 (enExample) |
| CN (1) | CN112955143B (enExample) |
| AU (1) | AU2019345297B2 (enExample) |
| BR (1) | BR112021005086A2 (enExample) |
| CA (1) | CA3113016A1 (enExample) |
| MX (1) | MX2021003156A (enExample) |
| SG (1) | SG11202102684VA (enExample) |
| TW (1) | TWI825177B (enExample) |
| WO (1) | WO2020061232A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017324510B2 (en) | 2016-09-07 | 2023-08-31 | Temple University - Of The Commonwealth System Of Higher Education | Compositions and methods for treatment of insulin resistance |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| TW202206062A (zh) | 2020-04-24 | 2022-02-16 | 美國坦普大學 高等教育聯邦系統 | 治療非酒精性脂肪肝炎的方法 |
| WO2022040324A1 (en) * | 2020-08-18 | 2022-02-24 | Metrea Biosciences, Inc. | COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13 |
| WO2023174543A1 (en) * | 2022-03-17 | 2023-09-21 | Siemens Industry Software GmbH | Managing artifact information relating to a physical system, especially improving traceability of re-baselined engineering-related information, method and system |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008100977A2 (en) | 2007-02-14 | 2008-08-21 | N.V. Organon | Carbamates therapeutic release agents as amidase inhibitors |
| CA2736177A1 (en) * | 2007-09-06 | 2009-03-12 | Boston Biomedical, Inc. | Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| US8889730B2 (en) * | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US20160031888A1 (en) * | 2013-03-13 | 2016-02-04 | Boston Biomedical, Inc. | 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer |
| WO2014202528A1 (en) | 2013-06-20 | 2014-12-24 | Boehringer Ingelheim International Gmbh | Olefin substituted oxindoles having ampk activity |
| EP2886541A1 (en) | 2013-12-19 | 2015-06-24 | Sanofi | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases |
| AU2015209095A1 (en) * | 2014-01-27 | 2016-07-07 | Boston Biomedical, Inc. | Novel methods for treating cancer |
| WO2017026119A1 (ja) * | 2015-08-10 | 2017-02-16 | 大日本住友製薬株式会社 | ５－（チアゾール－４－イル）インドリン－２－オン誘導体の精製方法 |
| US20170105996A1 (en) | 2015-10-16 | 2017-04-20 | Teva Pharmaceutical Industries, Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
| HK1257929A1 (zh) | 2015-11-06 | 2019-11-01 | Gemphire Therapeutics Inc. | 治疗混合性血脂异常 |
| WO2018005444A2 (en) * | 2016-06-28 | 2018-01-04 | Boston Biomedical, Inc. | Methods for treating cancer |
| JP7589949B2 (ja) * | 2018-09-18 | 2024-11-26 | １グローブ バイオメディカル カンパニー， リミテッド | 肥満に対する処置 |
-
2019
- 2019-09-18 WO PCT/US2019/051790 patent/WO2020061232A1/en not_active Ceased
- 2019-09-18 KR KR1020217011261A patent/KR102890555B1/ko active Active
- 2019-09-18 TW TW108133698A patent/TWI825177B/zh active
- 2019-09-18 AU AU2019345297A patent/AU2019345297B2/en active Active
- 2019-09-18 US US17/276,482 patent/US12318381B2/en active Active
- 2019-09-18 BR BR112021005086-8A patent/BR112021005086A2/pt unknown
- 2019-09-18 SG SG11202102684VA patent/SG11202102684VA/en unknown
- 2019-09-18 CN CN201980061364.1A patent/CN112955143B/zh active Active
- 2019-09-18 JP JP2021539501A patent/JP7557788B2/ja active Active
- 2019-09-18 MX MX2021003156A patent/MX2021003156A/es unknown
- 2019-09-18 EP EP19861804.3A patent/EP3852753A4/en active Pending
- 2019-09-18 CA CA3113016A patent/CA3113016A1/en active Pending
-
2024
- 2024-09-04 JP JP2024152701A patent/JP2024163257A/ja active Pending
-
2025
- 2025-05-19 US US19/212,109 patent/US20250275960A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022501436A5 (enExample) | ||
| CN114430739A (zh) | Egfr抑制剂、组合物及其制备方法 | |
| RU2015139590A (ru) | ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ | |
| JP2012507566A5 (enExample) | ||
| CA2703125A1 (en) | Pyrazinyl-substituted pyrrolo[2,3-b]pyridines, compositions thereof, and their use in the treatment of cancer | |
| RU2015143526A (ru) | Производные 3-(арил или гетероарил)метилениндолин-2-она в качестве ингибиторов киназного пути раковых стволовых клеток для лечения рака | |
| RU2017121044A (ru) | Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы | |
| KR20220086628A (ko) | Prmt5 저해제의 약학적 조합물 | |
| JP2019517487A5 (enExample) | ||
| RU2010150786A (ru) | Пирролопиридины как ингибиторы киназы | |
| RU2018104702A (ru) | Новые соединения пирролопиримидина в качестве ингибиторов протеинкиназ | |
| KR970001322A (ko) | 당뇨병 저해제로서의 치환 n-[인돌-2-카보닐]-글리신아미드 및 유도체 | |
| RU2016141647A (ru) | ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ | |
| IL291590B1 (en) | Novel modified quinoline-8-carbonitrile compounds with androgen receptor unblocking activity and their uses | |
| ME02906B (me) | Derivati pirazolopirolidina i njihova upotreba u liječenju bolesti | |
| JP2007519694A5 (enExample) | ||
| RU2014153627A (ru) | Имидазо[1, 2-]пиридазиновые производные как ингибиторы киназ | |
| JP2019507179A5 (enExample) | ||
| RU2009119181A (ru) | Гетероциклические соединения и их применение в качестве ингибиторов гликогенсинтаза-киназы-3 | |
| RU2014141674A (ru) | 3,5-диаминопиразоловые ингибиторы киназы | |
| IL269710B2 (en) | 2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in cancer therapy | |
| CA3127152A1 (en) | Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases | |
| FI3853218T3 (fi) | Somatostatiinin modulaattoreita ja niiden käyttöjä | |
| RU2017145928A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| RU2004110042A (ru) | Тиено[2,3-d] пиримидины с комбинированной агонистической активностью lh и fsh |